Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Jacobsen

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
BMC Cancer|July 28, 2017
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerFrank Jacobsen, Billurvan Taskin, Nathaniel Melling, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
Cells|May 13, 2023
Novel Filamin C Myofibrillar Myopathy Variants Cause Different Pathomechanisms and Alterations in Protein Quality SystemsDominik Sellung, Lorena Heil, Nassam Daya, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Neurology. Genetics|July 8, 2021
FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic DataRudolf Andre Kley, Yvonne Leber, Bertold Schrank, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Genes, Chromosomes & Cancer|January 10, 2019
5q21 deletion is often heterogeneous in prostate cancerMartina Kluth, Zaid Al Kilani, Cansu Özden, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
BMC Cancer|July 28, 2017
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerFrank Jacobsen, Billurvan Taskin, Nathaniel Melling, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
Cells|May 13, 2023
Novel Filamin C Myofibrillar Myopathy Variants Cause Different Pathomechanisms and Alterations in Protein Quality SystemsDominik Sellung, Lorena Heil, Nassam Daya, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Neurology. Genetics|July 8, 2021
FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic DataRudolf Andre Kley, Yvonne Leber, Bertold Schrank, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Genes, Chromosomes & Cancer|January 10, 2019
5q21 deletion is often heterogeneous in prostate cancerMartina Kluth, Zaid Al Kilani, Cansu Özden, et al.
Pageof 19